Right Prefrontal Cortical Thickness Is Associated With Response to Cognitive-Behavioral Therapy in Children With Obsessive-Compulsive Disorder.


Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
04 2023
Historique:
received: 13 03 2022
revised: 26 07 2022
accepted: 06 12 2022
pmc-release: 01 04 2024
medline: 3 4 2023
pubmed: 17 12 2022
entrez: 16 12 2022
Statut: ppublish

Résumé

Cognitive-behavioral therapy (CBT) is considered a first-line treatment for obsessive-compulsive disorder (OCD) in pediatric and adult populations. Nevertheless, some patients show partial or null response. The identification of predictors of CBT response may improve clinical management of patients with OCD. Here, we aimed to identify structural magnetic resonance imaging (MRI) predictors of CBT response in 2 large series of children and adults with OCD from the worldwide ENIGMA-OCD consortium. Data from 16 datasets from 13 international sites were included in the study. We assessed which variations in baseline cortical thickness, cortical surface area, and subcortical volume predicted response to CBT (percentage of baseline to post-treatment symptom reduction) in 2 samples totaling 168 children and adolescents (age range 5-17.5 years) and 318 adult patients (age range 18-63 years) with OCD. Mixed linear models with random intercept were used to account for potential cross-site differences in imaging values. Significant results were observed exclusively in the pediatric sample. Right prefrontal cortex thickness was positively associated with the percentage of CBT response. In a post hoc analysis, we observed that the specific changes accounting for this relationship were a higher thickness of the frontal pole and the rostral middle frontal gyrus. We observed no significant effects of age, sex, or medication on our findings. Higher cortical thickness in specific right prefrontal cortex regions may be important for CBT response in children with OCD. Our findings suggest that the right prefrontal cortex plays a relevant role in the mechanisms of action of CBT in children.

Identifiants

pubmed: 36526161
pii: S0890-8567(22)01972-4
doi: 10.1016/j.jaac.2022.07.865
pmc: PMC10065927
mid: NIHMS1857152
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-414

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH094613
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States

Investigateurs

Eva Real (E)
Cinto Segalas (C)
Astrid Morer (A)
Silvia Brem (S)
Sonia Ferreira (S)
Pedro Silva Moreira (PS)
Kristen Hagen (K)
Sayo Hamatani (S)
Jumpei Takahashi (J)
Tokiko Yoshida (T)
Maria Alice de Mathis (MA)
Euripedes C Miguel (EC)
Jose C Pariente (JC)
Jinsong Tang (J)

Informations de copyright

Copyright © 2022 American Academy of Child and Adolescent Psychiatry. All rights reserved.

Références

Am J Psychiatry. 2016 Sep 9;174(1):60-69
pubmed: 27609241
Eur Arch Psychiatry Clin Neurosci. 2019 Aug;269(5):587-598
pubmed: 30288559
J Affect Disord. 2022 Feb 1;298(Pt A):644-655
pubmed: 34800568
Depress Anxiety. 2022 Jan;39(1):37-48
pubmed: 34464485
Eur Neuropsychopharmacol. 2013 Jul;23(7):569-80
pubmed: 22841131
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Apr;3(4):320-328
pubmed: 29628064
Am J Psychiatry. 2018 May 1;175(5):453-462
pubmed: 29377733
Front Neuroinform. 2019 Jan 08;12:102
pubmed: 30670959
Psychol Med. 2020 Jan;50(1):146-160
pubmed: 30739618
Behav Res Ther. 2015 Jan;64:15-23
pubmed: 25463245
Biol Rev Camb Philos Soc. 2007 Nov;82(4):591-605
pubmed: 17944619
Mol Psychiatry. 2010 Jan;15(1):53-63
pubmed: 18725912
World J Biol Psychiatry. 2013 May;14(4):319-31
pubmed: 22746998
Lancet. 2009 Aug 8;374(9688):491-9
pubmed: 19665647
Neuropsychopharmacology. 2020 Jun;45(7):1232-1240
pubmed: 31952071
Depress Anxiety. 2021 Aug;38(8):836-845
pubmed: 34157177
J Psychiatry Neurosci. 2021 Nov 16;46(6):E628-E638
pubmed: 34785511
Psychiatry Res. 2015 Feb 28;225(3):236-46
pubmed: 25613661
World J Biol Psychiatry. 2014 Aug;15(6):443-52
pubmed: 24125065
Dialogues Clin Neurosci. 2007;9(2):141-51
pubmed: 17726913
Curr Top Behav Neurosci. 2021;49:269-300
pubmed: 33604877
Psychol Med. 2018 Apr;48(6):919-928
pubmed: 28826410
Int J Neuropsychopharmacol. 2002 Jun;5(2):181-91
pubmed: 12135542
Clin Psychol Rev. 2015 Aug;40:156-69
pubmed: 26117062
Neuroimage. 2007 Jul 15;36(4):1065-73
pubmed: 17513132
Psychiatry Res Neuroimaging. 2019 Feb 28;284:29-36
pubmed: 30641435
Neuroimage Clin. 2019;23:101877
pubmed: 31170685
Dev Neurosci. 2012;34(6):477-87
pubmed: 23257954
Psychol Med. 2014 Mar;44(4):845-56
pubmed: 23773479
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Br J Psychiatry. 2017 Jan;210(1):67-74
pubmed: 27198485
Front Psychiatry. 2017 Aug 15;8:143
pubmed: 28861007
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110037
pubmed: 32682876
J Affect Disord. 2016 Mar 15;193:175-84
pubmed: 26773910
JAMA. 2004 Oct 27;292(16):1969-76
pubmed: 15507582
Biol Psychiatry. 2010 Sep 1;68(5):416-24
pubmed: 20497902
J Child Psychol Psychiatry. 2020 Dec;61(12):1299-1308
pubmed: 31889307
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Ann N Y Acad Sci. 2012 Mar;1251:E1-24
pubmed: 23025352
Psychother Psychosom. 2020;89(4):228-241
pubmed: 32074624
Psychiatry Res Neuroimaging. 2016 May 30;251:53-9
pubmed: 27124424
Biopsychosoc Med. 2021 Oct 3;15(1):16
pubmed: 34602086
Cogn Emot. 2013;27(5):923-31
pubmed: 23237271

Auteurs

Sara Bertolín (S)

Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain; CIBERSAM, Barcelona, Spain.

Pino Alonso (P)

Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain; CIBERSAM, Barcelona, Spain; University of Barcelona, Barcelona, Spain.

Ignacio Martínez-Zalacaín (I)

Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain; University of Barcelona, Barcelona, Spain.

Jose M Menchón (JM)

Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain; CIBERSAM, Barcelona, Spain; University of Barcelona, Barcelona, Spain.

Susana Jimenez-Murcia (S)

Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain; University of Barcelona, Barcelona, Spain; CIBERobn, ISCIII, Spain.

Justin T Baker (JT)

McLean Hospital, Belmont, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Nuria Bargalló (N)

CIBERSAM, Barcelona, Spain; University of Barcelona, Barcelona, Spain; Image Diagnostic Center, Hospital Clinic, Barcelona, Spain; Magnetic Resonance Image Core Facility (IDIBAPS), Barcelona, Spain.

Marcelo Camargo Batistuzzo (MC)

Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil; Pontificial Catholic University of Sao Paulo, Brazil.

Premika S W Boedhoe (PSW)

Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands.

Brian P Brennan (BP)

McLean Hospital, Belmont, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Jamie D Feusner (JD)

University of California Los Angeles, Los Angeles, California; University of Toronto, Canada; Centre for Addiction and Mental Health, Toronto, Canada; Karolinksa Institutet, Stockholm, Sweden.

Kate D Fitzgerald (KD)

Columbia University, New York; The New York State Psychiatric Institute, New York.

Martine Fontaine (M)

Columbia University Medical College, Columbia University, New York.

Bjarne Hansen (B)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway; Centre for Crisis Psychology, University of Bergen, Bergen, Norway.

Yoshiyuki Hirano (Y)

Research Center for Child Mental Development, Chiba University, Chiba, Japan; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.

Marcelo Q Hoexter (MQ)

Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil; LiNC - Laboratory of Integrative Neuroscience of Universidade Federal de São Paulo (UNIFESP), Brazil.

Chaim Huyser (C)

Levvel, Academic Center for Child and Adolescent Psychiatry, Amsterdam, the Netherlands; Amsterdam UMC, Amsterdam, the Netherlands.

Neda Jahanshad (N)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California.

Fern Jaspers-Fayer (F)

University of British Columbia, Vancouver, Canada; British Columbia Children's Hospital Research Institute, Vancouver, Canada.

Masaru Kuno (M)

Research Center for Child Mental Development, Chiba University, Chiba, Japan.

Gerd Kvale (G)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway; University of Bergen, Bergen, Norway.

Luisa Lazaro (L)

CIBERSAM, Barcelona, Spain; University of Barcelona, Barcelona, Spain; IDIBAPS, Barcelona, Spain; Hospital Clínic, Barcelona, Spain.

Mafalda Machado-Sousa (M)

Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal; Clinical Academic Center - Braga, Braga, Portugal.

Rachel Marsh (R)

The New York State Psychiatric Institute, New York; Columbia University Medical College, Columbia University, New York.

Pedro Morgado (P)

Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal; Clinical Academic Center - Braga, Braga, Portugal.

Akiko Nakagawa (A)

Research Center for Child Mental Development, Chiba University, Chiba, Japan.

Luke Norman (L)

University of Michigan, Ann Arbor.

Erika L Nurmi (EL)

University of California Los Angeles, Los Angeles, California.

Joseph O'Neill (J)

UCLA Division of Child and Adolescent Psychiatry, Los Angeles, California; UCLA Brain Research Institute, Los Angeles, California.

Ana E Ortiz (AE)

IDIBAPS, Barcelona, Spain; Hospital Clínic, Barcelona, Spain.

Chris Perriello (C)

University of Illinois at Urbana Champaign, Champaign, Illinois.

John Piacentini (J)

UCLA Division of Child and Adolescent Psychiatry, Los Angeles, California; UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California.

Maria Picó-Pérez (M)

Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal; Clinical Academic Center - Braga, Braga, Portugal.

Roseli G Shavitt (RG)

Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.

Eiji Shimizu (E)

Research Center for Child Mental Development, Chiba University, Chiba, Japan; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.

Helen Blair Simpson (HB)

The New York State Psychiatric Institute, New York; Columbia University Medical College, Columbia University, New York.

S Evelyn Stewart (SE)

University of British Columbia, Vancouver, Canada; British Columbia Children's Hospital Research Institute, Vancouver, Canada; British Columbia Mental Health and Substance Use Services Research Institute, Vancouver, Canada.

Sophia I Thomopoulos (SI)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California.

Anders Lillevik Thorsen (AL)

Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway; Centre for Crisis Psychology, University of Bergen, Bergen, Norway.

Susanne Walitza (S)

University Hospital of Psychiatry Zurich, University of Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Switzerland.

Lidewij H Wolters (LH)

Levvel, Academic Center for Child and Adolescent Psychiatry, Amsterdam, the Netherlands.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California.

Odile A van den Heuvel (OA)

Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.

Dan J Stein (DJ)

SAMRC Unit on Risk and Resilience in Mental Disorders, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Carles Soriano-Mas (C)

Bellvitge Biomedical Research Institute-IDIBELL, Bellvitge University Hospital, Barcelona, Spain; CIBERSAM, Barcelona, Spain; University of Barcelona, Barcelona, Spain. Electronic address: csoriano@idibell.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH